PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 19 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $915,463 | +39.3% | 935,000 | 0.0% | 0.12% | +32.6% |
| Q1 2023 | $657,183 | -19.7% | 935,000 | 0.0% | 0.09% | -39.1% |
| Q4 2022 | $817,934 | -1.5% | 935,000 | 0.0% | 0.15% | +3.4% |
| Q3 2022 | $830,000 | +4.4% | 935,000 | 0.0% | 0.15% | +9.8% |
| Q2 2022 | $795,000 | -4.1% | 935,000 | 0.0% | 0.13% | +35.7% |
| Q1 2022 | $829,000 | -2.8% | 935,000 | 0.0% | 0.10% | +6.5% |
| Q4 2021 | $853,000 | +4.9% | 935,000 | 0.0% | 0.09% | +4.5% |
| Q3 2021 | $813,000 | -5.9% | 935,000 | 0.0% | 0.09% | -5.4% |
| Q2 2021 | $864,000 | – | 935,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cohanzick Management, LLC | 25,112,000 | $25,557,982 | 22.10% |
| Westchester Capital Management, LLC | 8,267,000 | $8,308,536 | 0.24% |
| MACQUARIE GROUP LTD | 5,359,000 | $5,386,000 | 0.01% |